[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense]




Скачать 217.57 Kb.
Название[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense]
страница6/8
Дата15.10.2012
Размер217.57 Kb.
ТипДокументы
1   2   3   4   5   6   7   8
Nippon Rinsho 63 (8): 1438-1442, 2005

Ohgari Y; Nakayasu Y; Kitajima S; Sawamoto M; Mori H; Shimokawa O; Matsui H; Taketani S. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: Relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. Biochem Pharmacol , 2005

Ohmori S; Masuda K; Yoshida M; Arai T; Nakajima S. The study of the characteristic of photocytotoxicity under high peak power pulsed irradiation with ATX-S10Na(II) in vitro. Lasers Med Sci 20 (2): 54-61, 2005

Oliveira CA; Machado AE; Pessine FB. Preparation of 100 nm diameter unilamellar vesicles containing zinc phthalocyanine and cholesterol for use in photodynamic therapy. Chem Phys Lipids 133 (1): 69-78, 2005

Oliver A; Ciulla TA; Comer GM. New and classic insights into presumed ocular histoplasmosis syndrome and its treatment. Curr Opin Ophthalmol 16 (3): 160-165, 2005

Olivier S; Harissi-Dagher M; Sebag M. Photodynamic therapy for chronic serous detachment of the retinal pigment epithelium in a young patient. Can J Ophthalmol 40 (2): 214-216, 2005

Oseroff AR; Shieh S; Frawley NP; Cheney R; Blumenson LE; Pivnick EK; Bellnier DA. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Arch Dermatol 141 (1): 60-67, 2005

Otsu K; Sato K; Ikeda Y; Imai H; Nakagawa Y; Ohba Y; Fujii J. An abortive apoptotic pathway induced by singlet oxygen is due to the suppression of caspase activation. Biochem J 389 (Pt 1): 197-206, 2005

Overholt BF; Lightdale CJ; Wang KK; Canto MI; Burdick S; Haggitt RC; Bronner MP; Taylor SL; Grace MG; Depot M. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62 (4): 488-498, 2005

Ozawa T; Afzal J; Lamborn KR; Bollen AW; Bauer WF; Koo MS; Kahl SB; Deen DF. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model. Int J Radiat Oncol Biol Phys 63 (1): 247-252, 2005

Pai M; Jamal W; Mosse A; Bishop C; Bown S; McEwan J. Inhibition of In-stent Restenosis in Rabbit Iliac Arteries with Photodynamic Therapy. Eur J Vasc Endovasc Surg , 2005

Pandey SK; Gryshuk AL; Sajjad M; Zheng X; Chen Y; Abouzeid MM; Morgan J; Charamisinau I; Nabi HA; Oseroff A; Pandey RK. Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible "see and treat" approach. J Med Chem 48 (20): 6286-6295, 2005

Panjehpour M; Overholt BF; Phan MN; Haydek JM. Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus: efficacy vs. incidence of stricture after treatment. Gastrointest Endosc 61 (1): 13-18, 2005

Parodi MB; Boscia F; Piermarocchi S; Ferrari TM; Furino C; Sborgia C. Variable outcome of photodynamic therapy for choroidal neovascularization associated with choroidal nevus. Retina 25 (4): 438-442, 2005

Paul HB; Welte T; Groneberg DA. [Drug transport in the respiratory epithelium]. Pneumologie 59 (7): 461-469, 2005

Pauleikhoff D; Bornfeld N; Gabel VP; Holz F; Roider H. [The Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists--comments on the current therapy for neovascular AMD]. Klin Monatsbl Augenheilkd 222 (5): 381-388, 2005

Paulino TP; Ribeiro KF; Thedei G, Jr.; Tedesco AC; Ciancaglini P. Use of hand held photopolymerizer to photoinactivate Streptococcus mutans. Arch Oral Biol 50 (3): 353-359, 2005

Pech O; Gossner L; May A; Rabenstein T; Vieth M; Stolte M; Berres M; Ell C. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc 62 (1): 24-30, 2005

Pegaz B; Debefve E; Borle F; Ballini JP; van den BH; Kouakou-Konan YN. Encapsulation of porphyrins and chlorins in biodegradable nanoparticles: the effect of dye lipophilicity on the extravasation and the photothrombic activity. A comparative study. J Photochem Photobiol B 80 (1): 19-27, 2005

Pegaz B; van den BH; Konan YN; Debefve E; Borle F; Ballini JP; Wagieres G; Spaniol S; Albrecht V; Scheglmann D; Nifantiev NE. Pre-clinical evaluation of a novel water-soluble chlorin e6 derivative (BLC 1010) as photosensitizer for the closure of the neovessels. Photochem Photobiol , 2005

Peiretti E; Klancnik JM, Jr.; Spaide RF; Yannuzzi L. Choroidal neovascularization in sorsby fundus dystrophy treated with photodynamic therapy and intravitreal triamcinolone acetonide. Retina 25 (3): 377-379, 2005

Peng TI; Chang CJ; Guo MJ; Wang YH; Yu JS; Wu HY; Jou MJ. Mitochondrion-targeted photosensitizer enhances the photodynamic effect-induced mitochondrial dysfunction and apoptosis. Ann N Y Acad Sci 1042: 419-428, 2005

Perentes Y; Van Tran T; Sickenberg M; Herbort CP. Subretinal neovascular membranes complicating uveitis: frequency, treatments, and visual outcome. Ocul Immunol Inflamm 13 (2-3): 219-224, 2005

Perry Y; Epperly MW; Fernando HC; Klein E; Finkelstein S; Greenberger JS; Luketich JD. Photodynamic therapy induced esophageal stricture--an animal model: from mouse to pig. J Surg Res 123 (1): 67-74, 2005

Peters F; Kara M; Rosmolen W; Aalders M; Ten Kate F; Krishnadath K; van Lanschot J; Fockens P; Bergman J. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. Endoscopy 37 (5): 418-424, 2005

Peters FP; Kara MA; Rosmolen WD; Aalders MC; Ten Kate FJ; Bultje BC; Krishnadath KK; Fockens P; van Lanschot JJ; van Deventer SJ; Bergman JJ. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc 61 (4): 506-514, 2005

Phan M; Dyke S; Whittaker MA; Simmerman A; Abrams S; Panjehpour M; Overholt BF. An Educational Tool for Photodynamic Therapy of Barrett Esophagus With High-Grade Dysplasia: From Screening Through Follow-Up. Gastroenterol Nurs 28 (5): 413-419, 2005

Pierard-Franchimont C; Henry F; Pierard GE. [Light therapy]. Rev Med Liege 60 Suppl 1: 109-117, 2005

Plaetzer K; Kiesslich T; Oberdanner CB; Krammer B. Apoptosis following photodynamic tumor therapy: induction, mechanisms and detection. Curr Pharm Des 11 (9): 1151-1165, 2005

Poriel C; Kessel D; Vicente MG. Stability of tin etiopurpurin. Photochem Photobiol 81 (1): 149-153, 2005

Potter MJ; Szabo SM; Ho T. Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl. Graefes Arch Clin Exp Ophthalmol : 1-3, 2005

Prasad AG; Gelder RN. Presumed ocular histoplasmosis syndrome. Curr Opin Ophthalmol 16 (6): 364-368, 2005

Prosst RL; Schroeter L; Gahlen J. Enhanced ALA-induced fluorescence in hyperparathyroidism. J Photochem Photobiol B 79 (1): 79-82, 2005

Qin Y; Xing D; Luo S; Zhou J; Zhong X; Chen Q. Feasibility of Using Fluoresceinyl Cypridina Luciferin Analog in a Novel Chemiluminescence Method for Real Time Photodynamic Therapy Dosimetry. Photochem Photobiol , 2005

Radakovic-Fijan S; Blecha-Thalhammer U; Kittler H; Honigsmann H; Tanew A. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study. J Am Acad Dermatol 53 (5): 823-827, 2005

Radakovic-Fijan S; Blecha-Thalhammer U; Schleyer V; Szeimies RM; Zwingers T; Honigsmann H; Tanew A. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. Br J Dermatol 152 (2): 279-283, 2005

Ragunath K; Krasner N; Raman VS; Haqqani MT; Phillips CJ; Cheung I. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Scand J Gastroenterol 40 (7): 750-758, 2005

Rahimipour S; Litichever-Coslovsky N; Alaluf M; Freeman D; Ehrenberg B; Weiner L; Mazur Y; Fridkin M; Koch Y. Novel methyl helianthrones as photosensitizers: synthesis and biological evaluation. Photochem Photobiol 81 (2): 250-258, 2005

Ramaswamy B; Manivasager V; Chin WW; Soo KC; Olivo M. Photodynamic diagnosis of a human nasopharyngeal carcinoma xenograft model using the novel Chlorin e6 photosensitizer Fotolon. Int J Oncol 26 (6): 1501-1506, 2005

Ramon PP; Brichet-Martin A; Fournier C. [Interventional bronchoscopy in the treatment of bronchial cancers.]. Rev Mal Respir , 2005

Rancan F; Helmreich M; Molich A; Jux N; Hirsch A; Roder B; Witt C; Bohm F. Fullerene-pyropheophorbide a complexes as sensitizer for photodynamic therapy: uptake and photo-induced cytotoxicity on Jurkat cells. J Photochem Photobiol B 80 (1): 1-7, 2005

Rancan F; Wiehe A; Nobel M; Senge MO; Omari SA; Bohm F; John M; Roder B. Influence of substitutions on asymmetric dihydroxychlorins with regard to intracellular uptake, subcellular localization and photosensitization of Jurkat cells. J Photochem Photobiol B 78 (1): 17-28, 2005

Ratanasukon M; Wongchaikunakorn N. Exudative retinal detachment after photodynamic therapy: a case report in an Asian patient. Eye , 2005

Ray R; Stinnett SS; Jaffe GJ. Evaluation of image artifact produced by optical coherence tomography of retinal pathology. Am J Ophthalmol 139 (1): 18-29, 2005

Reed MF; Tolis G, Jr.; Edil BH; Allan JS; Donahue DM; Gaissert HA; Moncure AC; Wain JC; Wright CD; Mathisen DJ. Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg 79 (4): 1110-1115, 2005

Rello S; Stockert JC; Moreno V; Gamez A; Pacheco M; Juarranz A; Canete M; Villanueva A. Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments. Apoptosis 10 (1): 201-208, 2005

Ris HB. Photodynamic therapy as an adjunct to surgery for malignant pleural mesothelioma. Lung Cancer 49 Suppl 1: S65-S68, 2005

Ritz R; Muller M; Weller M; Dietz K; Kuci S; Roser F; Tatagiba M. Hypericin: a promising fluorescence marker for differentiating between glioblastoma and neurons in vitro. Int J Oncol 27 (6): 1543-1549, 2005

Robey RW; Steadman K; Polgar O; Bates SE. ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy. Cancer Biol Ther 4 (2): 187-194, 2005

Robinson D. Special section: Monitoring Photodynamic Therapy. J Photochem Photobiol B 79 (3): 209, 2005

Romanko YS; Tsyb AF; Kaplan MA; Popuchiev VV. Relationship between antitumor efficiency of photodynamic therapy with photoditasine and photoenergy density. Bull Exp Biol Med 139 (4): 460-464, 2005

Rosenblatt BJ; Shah GK; Blinder K. Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization. Retina 25 (1): 33-37, 2005

Rosenfeld A; Morgan J; Goswami LN; Ohulchanskyy T; Zheng X; Prasad PN; Oseroff A; Pandey RK. Photosensitizers Derived From 132-Oxo-Methyl Pyropheophorbide-a. Photochem Photobiol , 2005

Rosenfeld PJ; Schwartz SD; Blumenkranz MS; Miller JW; Haller JA; Reimann JD; Greene WL; Shams N. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology 112 (6): 1048-1053, 2005

Sabharwal T; Morales JP; Irani FG; Adam A. Quality improvement guidelines for placement of esophageal stents. Cardiovasc Intervent Radiol 28 (3): 284-288, 2005

Saczko J; Kulbacka J; Chwilkowska A; Drag-Zalesiniska M; Wysocka T; Lugowski M; Banas T. The influence of photodynamic therapy on apoptosis in human melanoma cell line. Folia Histochem Cytobiol 43 (3): 129-132, 2005

Sadzuka Y; Tokutomi K; Iwasaki F; Sugiyama I; Hirano T; Konno H; Oku N; Sonobe T. The phototoxicity of photofrin was enhanced by PEGylated liposome in vitro. Cancer Lett , 2005

Sahni J; Stanga P; Wong D; Harding S. Optical coherence tomography in photodynamic therapy for subfoveal choroidal neovascularisation secondary to age related macular degeneration: a cross sectional study. Br J Ophthalmol 89 (3): 316-320, 2005

Sakharov DV; Elstak ED; Chernyak B; Wirtz KW. Prolonged lipid oxidation after photodynamic treatment. Study with oxidation-sensitive probe C11-BODIPY581/591. FEBS Lett 579 (5): 1255-1260, 2005

Salinas-Alaman A; Garcia-Layana A; Maldonado MJ; Sainz-Gomez C; Alvarez-Vidal A. Using optical coherence tomography to monitor photodynamic therapy in age related macular degeneration. Am J Ophthalmol 140 (1): 23-28, 2005

Salomon D. [Photodynamic therapy in dermatology, a new therapeutic tool]. Rev Med Suisse 1 (16): 1094-1098, 2005

Samkoe KS; Fecica MS; Goyan RL; Buccholz JL; Campbell C; Kelly NM; Cramb DT. Photobleaching Kinetics of Optically Trapped Multi-Lamellar Vesicles Containing Verteporfin Using Two-Photon Excitation. Photochem Photobiol , 2005

Sampliner RE. Managing Barrett's esophagus: what is new in 2005? Dis Esophagus 18 (1): 17-20, 2005

Sano M; Furuta T; Takahira K; Kajimura M; Hanai H; Kohno E; Hirano T; Hishida A. Cell-cycle-dependent efficacy of photodynamic therapy with ATX-S10(Na). Lasers Med Sci 20 (1): 1-5, 2005

Santos MA; Belo VG; Santos G. Effectiveness of photodynamic therapy with topical 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone in the treatment of acne vulgaris: comparative study. Dermatol Surg 31 (8 Pt 1): 910-915, 2005

Sarissky M; Lavicka J; Kocanova S; Sulla I; Mirossay A; Miskovsky P; Gajdos M; Mojzis J; Mirossay L. Diazepam enhances hypericin-induced photocytotoxicity and apoptosis in human glioblastoma cells. Neoplasma 52 (4): 352-359, 2005

Savellano MD; Pogue BW; Hoopes PJ; Vitetta ES; Paulsen KD. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates. Cancer Res 65 (14): 6371-6379, 2005

Savellano MD; Hasan T. Photochemical targeting of epidermal growth factor receptor: a mechanistic study. Clin Cancer Res 11 (4): 1658-1668, 2005

Savitskiy VP; Zorin VP; Potapnev MP. Accumulation of chlorine e6 derivatives in cells with different level of expression and function activity of multidrug resistance protein P-gp 170. Exp Oncol 27 (1): 47-51, 2005

Savoy AD; Wallace MB. EUS in the management of the patient with dysplasia in Barrett's esophagus. J Clin Gastroenterol 39 (4): 263-267, 2005

Saw CL; Olivo M; Soo KC; Heng PW. Delivery of hypericin for photodynamic applications. Cancer Lett , 2005

Saw CL; Heng PW; Chin WW; Soo KC; Olivo M. Enhanced photodynamic activity of hypericin by penetration enhancer N-methyl pyrrolidone formulations in the chick chorioallantoic membrane model. Cancer Lett , 2005

Saw CL; Olivo M; Chin WW; Soo KC; Heng PW. Transport of hypericin across chick chorioallantoic membrane and photodynamic therapy vasculature assessment. Biol Pharm Bull 28 (6): 1054-1060, 2005

Sayed Z; Harris F; Phoenix DA. A study on the bacterial photo-toxicity of phenothiazinium based photosensitisers.
1   2   3   4   5   6   7   8

Похожие:

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconSelected Anomalies and Diseases of the Eye

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconHepatic Liver Diseases – Methods for Diagnosis and

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconAbengoechea-hernandez, S., Elizalde-montagut, J. & Fideliz de la paz-dalisay, M. (2007) [Photodynamic therapy in adult-onset foveomacular vitelliform

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconБад «нагипол» в терапии алиментарно-зависимых патологий. Baa "nagipol" in therapy alimentary-dependent’s diseases
Ключевые слова: биологически-активная добавка (бад), пивные дрожжи, автолизат, алиментарно-зависимые патологии, витамины, аминокислоты,...
[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconEndometriosis. Gynaecological diseases of children and teenagers
...
[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconSession 2: Fourier Transform Infrared (ft ir) & Fluorescence Spectroscopy

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconThe American Occupational Therapy Foundation & American Occupational Therapy Association’s

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] icon2. Device choice

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] icon“Assistive Device for Calendar Production”

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconEye Tracking and e-Learning

Разместите кнопку на своём сайте:
Библиотека


База данных защищена авторским правом ©lib.znate.ru 2014
обратиться к администрации
Библиотека
Главная страница